- CVS Health (NYSE:CVS) faces a new lawsuit alleging the company purposefully overcharged pharmacy customers for generic drugs.
- The legal action seeks class-action status from a judge and an order prohibiting CVS from pricing above co-payment levels.
- The company says it hasn't reviewed the lawsuit yet.
CVS Health hit by overcharging lawsuit
Recommended For You
About CVS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CVS | - | - |
CVS Health Corporation |